New research highlights why buprenorphine has been underutilized. Showing that even when it is prescribed to patients with an opioid use disorder, recovery success rates are fairly low. Of the 20,124 people studied who were prescribed Suboxone for addiction, the researchers found that 27 percent used another opioid during treatment and 54 percent received one after treatment was over, The Washington Post reports. The findings were published in the journal Addiction.
It is widely agreed upon that the longer one undergoes addiction treatment, the more equipped they will be for achieving long-term recovery. The longer the treatment, the stronger one's recovery will be. Yet, the research shows that the average length of stay on buprenorphine was 55 days, according to the article. More than a month shorter than 90-day treatment programs that have become commonplace across the country.
The study also brings to light how the health care system in America is not coordinating their efforts. Caleb Alexander, co-director of the Center for Drug Safety and Effectiveness at the Johns Hopkins Bloomberg School of Public Health, said that the research: "raises important questions about the quality of care these patients are receiving and the degree to which their care is coordinated across our fragmented health-care system."
Alexander pointed out that doctors are still not utilizing the prescription drug monitoring programs (PDMP), the article reports. He says that when patients continue to fill prescriptions for painkillers while also being prescribed Suboxone, it isn’t indicative of addicts gaming the system. It has more to do with “inefficiency and poor communication” throughout the healthcare system.
"Many doctors don’t use them [PDMPs]. Many doctors aren’t even registered. Many who are registered don’t use them regularly," says Alexander. "I don’t think we can put this entirely on patients or providers or any other single stakeholder."